Chinese venture capital firms Frontline BioVentures and WuXi Healthcare Ventures have agreed to merge to form a healthcare investment group named 6 Dimensions Capital, which will have combined assets under management (AUM) of RMB 5.5 billion ($800 million).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
